Direkt zum Inhalt
Merck

Lipid nanoparticles for brain targeting I. Formulation optimization.

International journal of pharmaceutics (2011-08-11)
Paolo Blasi, Stefano Giovagnoli, Aurélie Schoubben, Carmelo Puglia, Francesco Bonina, Carlo Rossi, Maurizio Ricci
ZUSAMMENFASSUNG

The aim of this study was to optimize the formulation of lipid nanoparticles (NPs), intended for brain targeting, with the aid of a computer generated experimental design. The high pressure homogenization technique, selected for this purpose, was suitable to formulate the 3 investigated lipids (i.e., Softisan(®) 142, SOFT; Compritol(®) 888 ATO, COMP; cetyl palmitate, CP) into nanometre-length particles, while the computer generated experimental design helped to individuate the best preparation conditions with a small number of experimental assay. Even though all the 3 optimized formulations were suitable for intravenous infusion, CP NPs showed the smallest particle size and the appropriate thermal behaviour to be used as carriers in brain targeting applications.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Palmitinsäure-palmitylester, ≥99%
Supelco
Cetylpalmitat, Pharmaceutical Secondary Standard; Certified Reference Material